Intervention

LPV/r

ClinicalTrials.gov intervention label

Clinical trials9
Recruiting0
Common conditions6
Lead sponsors shown6

Clinical trials

9 shown
Latency and Early Neonatal Provision of Antiretroviral Drugs Clinical TrialNCT02431975 · 2015-08-01
COMPLETED
Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIVNCT02016924 · 2014-01-16
ACTIVE_NOT_RECRUITING
Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis TherapyNCT01138202 · 2010-11-01
COMPLETED
Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected PatientsNCT00978237 · 2009-10-01
COMPLETED
Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based RegimensNCT00627055 · 2008-05-01
COMPLETED
Lopinavir/Ritonavir Monotherapy in ChildrenNCT00626301 · 2007-11-01
COMPLETED
Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV TherapyNCT00437476 · 2007-02-01
UNKNOWN
Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) TherapyNCT00437684 · 2007-02-01
UNKNOWN
Kaletra Sex/Gender Pharmacokinetics (PK) StudyNCT00148759 · 2005-06-01
COMPLETED

Trial status mix

COMPLETED6
UNKNOWN2
ACTIVE_NOT_RECRUITING1

Phase mix

PHASE45
PHASE33
PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.